•  
  •  
 

Abstract

Objectives. The study was to explore the association between Parkinson’s disease and proton pump inhibitors use. Methods. A population-based case-control study was conducted to analyze the 2000-2013 database of Taiwan National Health Insurance

Program. In total, there were 4280 participants aged ≥ 65 years with newly diagnosed Parkinson’s disease as the case group and 4280 sex- and age-matched participants without Parkinson’s disease as the control group. Ever use of proton pump inhibitors was defined as participants who had at least a prescription for proton pump inhibitors before the index date. Never use of proton pump inhibitors was defined as participants who did not have a prescription for proton pump inhibitors before the index date. The odds ratio and 95% confidence interval were used to estimate the association between Parkinson’s disease and proton pump inhibitors use by the logistic regression model. Results. A significant association was detected between Parkinson’s disease and proton pump inhibitors use (odds ratio 1.15, 95% confidence interval 1.04-1.27).

Conclusions. An association is found between Parkinson’s disease and proton pump inhibitors use in older people. Other real-world data are required to confirm the clinical impact of proton pump inhibitors therapy on the risk of Parkinson’s disease.

Creative Commons License

Creative Commons Attribution 4.0 License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS